dokumendiregister.ee
OtsingAsutusedMCP
Otsing›Terviseamet
Sissetulev dokumentAvalik

Infokiri

Terviseamet · 28. november 2024
Viit
13.2-7/24/12358-1
Registreeritud
28. november 2024
Dokumendi liik
Sissetulev dokument
Adressaat
SANTE
Saabumis/saatmisviis
e-post
Funktsioon
13.2 SULETUD 2025 Nakkushaiguste labor
Sari
13.2-7 NHL kirjavahetus
Toimik
13.2-7/2024
Vastutaja
Janne Pullat (TA, Peadirektori asetäitja (2) vastutusvaldkond, Rahvatervise labor, Nakkushaiguste labor)

Failid

  • 📎RE_ For Action_ Meeting documents follow up - Annual Joint NFP for Surveillance and NFP for Microbiology meeting_ Stockholm 23-2.msg397 KB

Sisu (failidest)

Saatja: CASTRO ALVAREZ Javier <[email protected]> Saaja: ECDC Microbiology, JOURDAIN Frédéric, MOULY Damien, ZANETTI Laura, dmi-codir, CHE Didier, YAMADA Ami, VISO Anne-Catherine, COIGNARD Bruno, PHF Support, Benka Bernhard, yves.dupont, Nikolay Bogdanov, Valentinos Silvestros, Jan Kynčl, Sidsel Skou Voss, Kärt Sõber, Tuija Leino, NOEL Harold, Diercke, Michaela, Kassiani Mellou, hajdu.agnes, Anna Margrét Guðmundsdóttir - Landl, Phil Downes, Bonfigli Sandro, Giedrė Aleksienė, Loes Soetens, hilde.klovstad, Løvlie, Astrid Louise, Sadkowska-Todys Małgorzata, Pedro Licinio Pinto Leite, Anca Sirbu, Mária Avdičová, veronika.ucakar, mvarelam, anneli.carlander, Indra Alexander, steven.vangucht, stefka.krumova, ljiljana.zmak, ckaragiannis, pavla.krizova, Eva Møller Nielsen, Janne Pullat, Salmenlinna Saara, WernerG, Ιωάννα Σπηλιοπούλου, henczko.judit, Hjördís Harðardóttir, Karl Gústaf Kristinsson, Kirsten Schaffer, Susanna Frost, annateresa.palamara, Stefanelli Paola, gatis.pakarna, algirdas.griskevicius, christopher.barbara, bettie.voordouw, Christine Genevieve Monceyron Jonassen, Karoline Bragstad, a.skoczynska, Helena Cortes Martins, Raluca Gatej, teodora.vremera, lucia.madarova, Andrej Steyer, ijado, Horacio Gil Gil, [email protected], KUIPERS Yoline, Vicky Lefevre, Bruno Ciancio, Daniel Palm, Phillip Zucs, Gianfranco Spiteri, Julien Beaute, Erik Alm, Riccardo Malacalza, Theresa Enkirch, Ann-Christin Lugg, Georgeta Mureanu, Maximilian Riess Teema: RE: For Action: Meeting documents follow up - Annual Joint NFP for Surveillance and NFP for Microbiology meeting, Stockholm 23-24 October 2024 (MET-000057) Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Dear ECDC colleagues, Santé publique France salutes the efforts of ECDC in encouraging Member States to develop infrastructure dedicated to wastewater surveillance. We have carefully revised the proposed document, which is a good debriefing of the main issues concerning the implementation of WBS. We do, however, have some suggestions of improvement or demands for clarification concerning certain points: - The complexity in WBS data issued from different sources (even when working at a national level) implies that it should be treated as being qualitative in nature, avoiding the temptation of doing analyses using a quantitative approach. It should be clearly stated in the document that WBS data should always be used in complement to other epidemiological data, and never as an independent indicator. - The document insists on the importance of ensuring data comparability between different sources and the use of standardization methods to this end. We want to point out that the use of such methods is normally intended to enable data comparability along different timepoints, and not sampling sites. WBS data is difficult to compare between sources, even at a national level. - Regional specificities (including geographical characteristics of each MS) should be taken in consideration during all steps of the implementation of WBS, from pathogen selection (different Member States may have different needs to address) to data collection and analysis. The cost/benefit evaluation that each MS may do on the implementation of wastewater-based surveillance will always be affected by these regional specificities, which this have a direct consequence in the decisions concerning pathogen prioritization. - It is no clearly specified the way in which ECDC and Member States will articulate the reflections on pathogen prioritization with initiatives such as EU-WISH (for which results are expected by end of 2026, at the latest). - Developments should be made on the public health objectives of this surveillance and on the measures that would be put in place following signals of detection/changes in pathogen circulation thanks to this system. - There is no mention in the document on how to address biosafety regulations in place in some countries that could affect the implementation of WBS. Concerning France, our biosafety regulations demand certifications for all steps of the microbiological surveillance of certain pathogens (from sampling to analysis, conservation and disposal of biological material) and this could heavily affect the logistics of laboratories involved in WBS. - Finally, and for the specific case of polio, the document should address the importance of polio WBS around Poliovirus Essential Facilities (including reference laboratories) as well as the areas of population at higher risk or having a lesser vaccine coverage. It should be also clearly specified how European wastewater-based polio surveillance would articulate with the WHO-driven initiatives and how double reporting would be avoided. Hoping that these points will be taken into consideration, yours sincerely, Javier CASTRO ALVAREZ, Ph.D. Coordonnateur de programme «Surveillance Génomique» Direction des Maladies Infectieuses +33 (0)1 71 80 1740 www.santepubliquefrance.fr <http://www.santepubliquefrance.fr/> De : ECDC Microbiology <[email protected]> Envoyé : jeudi 7 novembre 2024 10:54 À : PHF Support <[email protected]>; Benka Bernhard <[email protected]>; yves.dupont <[email protected]>; Nikolay Bogdanov <[email protected]>; Valentinos Silvestros <[email protected]>; Jan Kynčl <[email protected]>; Sidsel Skou Voss <[email protected]>; Kärt Sõber <[email protected]>; Tuija Leino <[email protected]>; NOEL Harold <[email protected]>; Diercke, Michaela <[email protected]>; Kassiani Mellou <[email protected]>; hajdu.agnes <[email protected]>; Anna Margrét Guðmundsdóttir - Landl <[email protected]>; Phil Downes <[email protected]>; Bonfigli Sandro <[email protected]>; Giedrė Aleksienė <[email protected]>; Loes Soetens <[email protected]>; hilde.klovstad <[email protected]>; Løvlie, Astrid Louise <[email protected]>; Sadkowska-Todys Małgorzata <[email protected]>; Pedro Licinio Pinto Leite <[email protected]>; Anca Sirbu <[email protected]>; Mária Avdičová <[email protected]>; veronika.ucakar <[email protected]>; mvarelam <[email protected]>; anneli.carlander <[email protected]>; Indra Alexander <[email protected]>; steven.vangucht <[email protected]>; stefka.krumova <[email protected]>; ljiljana.zmak <[email protected]>; ckaragiannis <[email protected]>; pavla.krizova <[email protected]>; Eva Møller Nielsen <[email protected]>; Janne Pullat <[email protected]>; Salmenlinna Saara <[email protected]>; CASTRO ALVAREZ Javier <[email protected]>; WernerG <[email protected]>; Ιωάννα Σπηλιοπούλου <[email protected]>; henczko.judit <[email protected]>; Hjördís Harðardóttir <[email protected]>; Karl Gústaf Kristinsson <[email protected]>; Kirsten Schaffer <[email protected]>; Susanna Frost <[email protected]>; annateresa.palamara <[email protected]>; Stefanelli Paola <[email protected]>; gatis.pakarna <[email protected]>; algirdas.griskevicius <[email protected]>; christopher.barbara <[email protected]>; bettie.voordouw <[email protected]>; Christine Genevieve Monceyron Jonassen <[email protected]>; Karoline Bragstad <[email protected]>; a.skoczynska <[email protected]>; Helena Cortes Martins <[email protected]>; Raluca Gatej <[email protected]>; teodora.vremera <[email protected]>; lucia.madarova <[email protected]>; Andrej Steyer <[email protected]>; ijado <[email protected]>; Horacio Gil Gil <[email protected]>; [email protected] Cc : KUIPERS Yoline <[email protected]>; Vicky Lefevre <[email protected]>; Bruno Ciancio <[email protected]>; Daniel Palm <[email protected]>; Phillip Zucs <[email protected]>; Gianfranco Spiteri <[email protected]>; Julien Beaute <[email protected]>; Erik Alm <[email protected]>; Riccardo Malacalza <[email protected]>; Theresa Enkirch <[email protected]>; Ann-Christin Lugg <[email protected]>; Georgeta Mureanu <[email protected]>; Maximilian Riess <[email protected]> Objet : For Action: Meeting documents follow up - Annual Joint NFP for Surveillance and NFP for Microbiology meeting, Stockholm 23-24 October 2024 (MET-000057) <https://store.santepubliquefrance.fr/7f7ae2f7e424fafbc134bd7d2c67bcb7> ECDC concept for integrati....docx <https://store.santepubliquefrance.fr/7f7ae2f7e424fafbc134bd7d2c67bcb7> (276.6 Ko) ⚠️ Message externe Dear colleagues, Thank you again for attending the Annual Joint NFP for Surveillance and NFP for Microbiology meeting, Stockholm 23-24 October 2024. One of the sessions was focussed on wastewater-based surveillance and we discussed the recast of the Urban Wastewater Treatment Directive, country experiences as well as country and ECDC perspectives on this topic. Please find attached as promised the draft ECDC concept for integration of wastewater data in surveillance of infectious diseases at EU/EEA-level in word format to provide your feedback and considerations within 3 weeks until 28 Nov 2024. ECDC plans to publish the final document as ECDC output on the webpage. Kind regards, The ECDC Microbiology Team European Centre for Disease Prevention and Control (ECDC)​​​​ Gustav III:s boulevard 40, 169 73 Solna, Sweden Phone +46 (0)8 58 60 10 00 www.ecdc.europa.eu <https://www.ecdc.europa.eu/> Follow ECDC on: <http://www.facebook.com/ECDC.EU> <http://twitter.com/ecdc_eu> <http://www.linkedin.com/company/ecdc> <http://www.youtube.com/user/ECDCchannel> Classified as ECDC NORMAL  From: PHF Support <[email protected] <mailto:[email protected]> > Sent: 16 October 2024 17:54 To: Benka Bernhard <[email protected] <mailto:[email protected]> >; yves.dupont <[email protected] <mailto:[email protected]> >; Nikolay Bogdanov <[email protected] <mailto:[email protected]> >; Valentinos Silvestros <[email protected] <mailto:[email protected]> >; Jan Kynčl <[email protected] <mailto:[email protected]> >; Sidsel Skou Voss <[email protected] <mailto:[email protected]> >; Kärt Sõber <[email protected] <mailto:[email protected]> >; Tuija Leino <[email protected] <mailto:[email protected]> >; Harold NOEL <[email protected] <mailto:[email protected]> >; Diercke, Michaela <[email protected] <mailto:[email protected]> >; Kassiani Mellou <[email protected] <mailto:[email protected]> >; hajdu.agnes <[email protected] <mailto:[email protected]> >; Anna Margrét Guðmundsdóttir - Landl <[email protected] <mailto:[email protected]> >; Phil Downes <[email protected] <mailto:[email protected]> >; Bonfigli Sandro <[email protected] <mailto:[email protected]> >; Giedrė Aleksienė <[email protected] <mailto:[email protected]> >; Loes Soetens <[email protected] <mailto:[email protected]> >; hilde.klovstad <[email protected] <mailto:[email protected]> >; Løvlie, Astrid Louise <[email protected] <mailto:[email protected]> >; Sadkowska-Todys Małgorzata <[email protected] <mailto:[email protected]> >; Pedro Licinio Pinto Leite <[email protected] <mailto:[email protected]> >; Anca Sirbu <[email protected] <mailto:[email protected]> >; Mária Avdičová <[email protected] <mailto:[email protected]> >; veronika.ucakar <[email protected] <mailto:[email protected]> >; mvarelam <[email protected] <mailto:[email protected]> >; anneli.carlander <[email protected] <mailto:[email protected]> >; Indra Alexander <[email protected] <mailto:[email protected]> >; steven.vangucht <[email protected] <mailto:[email protected]> >; stefka.krumova <[email protected] <mailto:[email protected]> >; ljiljana.zmak <[email protected] <mailto:[email protected]> >; ckaragiannis <[email protected] <mailto:[email protected]> >; pavla.krizova <[email protected] <mailto:[email protected]> >; Eva Møller Nielsen <[email protected] <mailto:[email protected]> >; Janne Pullat <[email protected] <mailto:[email protected]> >; Salmenlinna Saara <[email protected] <mailto:[email protected]> >; CASTRO-ALVAREZ Javier <[email protected] <mailto:[email protected]> >; WernerG <[email protected] <mailto:[email protected]> >; Ιωάννα Σπηλιοπούλου <[email protected] <mailto:[email protected]> >; henczko.judit <[email protected] <mailto:[email protected]> >; Hjördís Harðardóttir <[email protected] <mailto:[email protected]> >; Karl Gústaf Kristinsson <[email protected] <mailto:[email protected]> >; Kirsten Schaffer <[email protected] <mailto:[email protected]> >; Susanna Frost <[email protected] <mailto:[email protected]> >; annateresa.palamara <[email protected] <mailto:[email protected]> >; Stefanelli Paola <[email protected] <mailto:[email protected]> >; gatis.pakarna <[email protected] <mailto:[email protected]> >; algirdas.griskevicius <[email protected] <mailto:[email protected]> >; christopher.barbara <[email protected] <mailto:[email protected]> >; bettie.voordouw <[email protected] <mailto:[email protected]> >; Christine Genevieve Monceyron Jonassen <[email protected] <mailto:[email protected]> >; Karoline Bragstad <[email protected] <mailto:[email protected]> >; a.skoczynska <[email protected] <mailto:[email protected]> >; Helena Cortes Martins <[email protected] <mailto:[email protected]> >; Raluca Gatej <[email protected] <mailto:[email protected]> >; teodora.vremera <[email protected] <mailto:[email protected]> >; lucia.madarova <[email protected] <mailto:[email protected]> >; Andrej Steyer <[email protected] <mailto:[email protected]> >; ijado <[email protected] <mailto:[email protected]> >; Horacio Gil Gil <[email protected] <mailto:[email protected]> >; [email protected] <mailto:[email protected]> Cc: KUIPERS Yoline <[email protected] <mailto:[email protected]> >; Vicky Lefevre <[email protected] <mailto:[email protected]> >; Bruno Ciancio <[email protected] <mailto:[email protected]> >; Daniel Palm <[email protected] <mailto:[email protected]> >; Phillip Zucs <[email protected] <mailto:[email protected]> >; Gianfranco Spiteri <[email protected] <mailto:[email protected]> >; Julien Beaute <[email protected] <mailto:[email protected]> >; Erik Alm <[email protected] <mailto:[email protected]> >; Riccardo Malacalza <[email protected] <mailto:[email protected]> >; Theresa Enkirch <[email protected] <mailto:[email protected]> >; Ann-Christin Lugg <[email protected] <mailto:[email protected]> >; Georgeta Mureanu <[email protected] <mailto:[email protected]> >; PHF Support <[email protected] <mailto:[email protected]> > Subject: Meeting documents - Annual Joint NFP for Surveillance and NFP for Microbiology meeting, Stockholm 23-24 October 2024 (MET-000057) Dear colleagues, We are looking forward to meeting you next week at the Annual Joint NFP for Surveillance and NFP for Microbiology meeting taking place in Stockholm on 23-24 October 2024. Please find attached the draft agenda and other meeting documents which we kindly ask you to read through ahead of the meeting, if possible, so that you will be able to participate in the discussions. 1. Draft meeting agenda 2. Draft IA art. 13 List of diseases v6 (session 1) 3. Draft IA art. 13 Network operation v10 (session 1) 4. Draft IA art. 14 EpiPulse specs v5 (session 1) 5. Draft DA art. 14 EpiPulse access v3 (session 1) 6. Draft DA art. 14 Surveillance system requirements v6 (session 1) 7. ECDC concept for integration of wastewater data in surveillance of infectious diseases at EUEEA-level v1 (session 6) Kind regards, Ann-Christin Lugg on behalf of Bruno Ciancio and Daniel Palm Classified as ECDC NORMAL  Confidentiality Notice If you are not the intended recipient of this message, you are hereby kindly requested, to, consecutively, refrain from disclosing its content to any third party, delete it and inform its sender of the erroneous transmittal.
Allikas: Terviseamet dokumendiregister →
dokumendiregister.eeAsutusedEesti avalike dokumendiregistrite otsing · nimistu.ee andmetel